NO943347L - Halichondriner og beslektede forbindelser - Google Patents

Halichondriner og beslektede forbindelser

Info

Publication number
NO943347L
NO943347L NO943347A NO943347A NO943347L NO 943347 L NO943347 L NO 943347L NO 943347 A NO943347 A NO 943347A NO 943347 A NO943347 A NO 943347A NO 943347 L NO943347 L NO 943347L
Authority
NO
Norway
Prior art keywords
halichondrins
related compounds
norhalichondrin
halichondrin
synthesis
Prior art date
Application number
NO943347A
Other languages
English (en)
Norwegian (no)
Other versions
NO943347D0 (no
Inventor
Yoshito Kishi
Francis Fang
Craig J Forsyth
Paula M Scola
Suk Kyoon Yoon
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of NO943347D0 publication Critical patent/NO943347D0/no
Publication of NO943347L publication Critical patent/NO943347L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
NO943347A 1992-03-12 1994-09-09 Halichondriner og beslektede forbindelser NO943347L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84976992A 1992-03-12 1992-03-12
PCT/US1993/002330 WO1993017690A1 (en) 1992-03-12 1993-03-12 Halichondrins and related compounds

Publications (2)

Publication Number Publication Date
NO943347D0 NO943347D0 (no) 1994-09-09
NO943347L true NO943347L (no) 1994-11-09

Family

ID=25306481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943347A NO943347L (no) 1992-03-12 1994-09-09 Halichondriner og beslektede forbindelser

Country Status (14)

Country Link
US (1) US5338865A (de)
EP (1) EP0642345B1 (de)
JP (1) JPH07504664A (de)
KR (1) KR950700308A (de)
AT (1) ATE196138T1 (de)
AU (1) AU674673B2 (de)
CA (1) CA2130905A1 (de)
DE (1) DE69329383D1 (de)
FI (1) FI944178A0 (de)
HU (1) HUT70956A (de)
NO (1) NO943347L (de)
NZ (1) NZ251177A (de)
RU (1) RU2112773C1 (de)
WO (1) WO1993017690A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399717A (en) * 1993-09-29 1995-03-21 Merck & Co., Inc. Glycosidation route to 4"-epi-methylamino-4"-deoxyavermectin B1
IL139960A0 (en) * 1998-06-17 2002-02-10 Eisai Co Ltd Macrocylic analogs and methods of their use and preparation
US8097648B2 (en) * 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
CN101899026B (zh) 2004-06-03 2016-08-03 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
CN109180615A (zh) * 2004-06-03 2019-01-11 卫材R&D管理有限公司 用于制备软海绵素b的类似物的中间体
US20060045846A1 (en) * 2004-08-30 2006-03-02 Horstmann Thomas E Reagents and methods for labeling terminal olefins
BRPI0817909B1 (pt) * 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
JP6001857B2 (ja) * 2008-04-04 2016-10-05 エーザイ・アール・アンド・ディー・マネジメント株式会社 ハリコンドリンb類似体
BR112012018232B8 (pt) 2010-01-26 2023-01-10 Eisai R&D Man Co Ltd Compostos derivados de furo [3,2-b] pirano úteis na síntese de análogos de halicondrina b e métodos de sintetização de er-80402 e de eribulina
EP2785687B1 (de) 2011-11-30 2019-02-20 Sandoz AG Verfahren zur herstellung von (3r-)2,4-di-abganbgsgruppen-3-methylbut-1-en
EP2791123B1 (de) 2011-12-16 2018-07-18 Sandoz AG Verfahren zur herstellung von 3-((2s, 5s)-4-methylen-5-(3-oxopropyl) tetrahydrofuran-2-yl)-propanolderivaten und zwischenprodukte davon
AU2012363334B2 (en) 2011-12-29 2017-02-02 Alphora Research Inc. 2-((2s,3s,4r,5r)-5-((s)-3-amino-2-hydroxyprop-1-yl)-4-methoxy-3-(phenylsulfonylmethyl) tetrahydrofuran-2-yl)acetaldehyde derivatives and process for their preparation
CN104334562A (zh) 2012-03-30 2015-02-04 阿方拉研究股份有限公司 用于制备软海绵素b的大环c1-酮类似物的合成方法及其中有用的中间体
WO2014183211A1 (en) 2013-05-15 2014-11-20 Alphora Research Inc. 3-((2s,5s)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof
AU2014286880B2 (en) 2013-07-03 2017-12-14 Sandoz Ag Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing -SO2-(p-TOLYL) groups
HUE049387T2 (hu) 2013-11-04 2020-09-28 Eisai R&D Man Co Ltd A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek
SG10201805024YA (en) 2013-12-06 2018-07-30 Eisai R&D Man Co Ltd Methods useful in the synthesis of halichondrin b analogs
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
MX380284B (es) * 2015-05-07 2025-03-12 Eisai R&D Man Co Ltd Reacciones de macrociclización e intermediarios y otros fragmentos útiles en la síntesis de macrólidos de halicondrina.
US10676481B2 (en) 2016-02-12 2020-06-09 Eisai R&D Management Co., Ltd. Intermediates in the synthesis of eribulin and related methods of synthesis
SG11201811671XA (en) 2016-06-30 2019-01-30 Eisai R&D Man Co Ltd Prins reaction and intermediates useful in the synthesis of halichondrin macrolides and analogs thereof
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
JP7168580B2 (ja) 2017-04-05 2022-11-09 プレジデント アンド フェローズ オブ ハーバード カレッジ 大環状化合物およびその使用
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
JP7266267B2 (ja) * 2017-07-06 2023-04-28 プレジデント アンド フェローズ オブ ハーバード カレッジ Fe/cu媒介ケトン合成
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
IL295588B2 (en) 2017-07-06 2024-03-01 Harvard College Synthesis of halichondrins
ES2974243T3 (es) * 2017-11-15 2024-06-26 Harvard College Compuestos macrocíclicos y usos de los mismos
KR20250057138A (ko) 2018-01-03 2025-04-28 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤리드 및 그의 유사체의 합성에 유용한 프린스 반응 및 화합물
CN111285894B (zh) 2018-12-10 2021-03-05 北京天一绿甫医药科技有限公司 用于制备软海绵素类化合物的中间体及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9206244D0 (en) * 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge

Also Published As

Publication number Publication date
NZ251177A (en) 1996-10-28
HUT70956A (en) 1995-11-28
FI944178L (fi) 1994-09-09
ATE196138T1 (de) 2000-09-15
DE69329383D1 (de) 2000-10-12
RU94042393A (ru) 1996-07-20
KR950700308A (ko) 1995-01-16
EP0642345A1 (de) 1995-03-15
EP0642345A4 (en) 1995-04-19
RU2112773C1 (ru) 1998-06-10
CA2130905A1 (en) 1993-09-16
WO1993017690A1 (en) 1993-09-16
AU3808293A (en) 1993-10-05
FI944178A7 (fi) 1994-09-09
HU9402600D0 (en) 1994-12-28
EP0642345B1 (de) 2000-09-06
AU674673B2 (en) 1997-01-09
JPH07504664A (ja) 1995-05-25
FI944178A0 (fi) 1994-09-09
NO943347D0 (no) 1994-09-09
US5338865A (en) 1994-08-16

Similar Documents

Publication Publication Date Title
NO943347L (no) Halichondriner og beslektede forbindelser
FI925211A0 (fi) Isoxazol-4-karboxylsyraamider och hydroxialkylidencyanaettiksyraamider,laekemedel innehaollande dessa och anvaendning av dessa
DK0726899T3 (da) Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler
ES2193252T3 (es) Quinolonas y su uso terapeutico.
NO892894D0 (no) Nye kondenserte heterocykliske forbindelser.
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
BG101002A (bg) Заместени арилалкилтио-алкилтиопиридини и използване за борба с бактерии от рода helicobacter
NO954328L (no) Nye substituerte 1-fenyl-pyridinyl-benzotriazoler
ATE81976T1 (de) 2-pyrimidinyl-1-piperazin-derivate zur behandlung von alkoholismus.
SE8101311L (sv) Heterocykliska foreningar
NO951136L (no) Syntese av N-acetyl neuraminsyre-derivater
ATE87844T1 (de) Reaktorvorrichtung zur grossflaechigen durchstroemung von wanderbettschuettungen.
EP0199447A3 (de) Gerät zur Detektion und Vernichtung eindringender Objekte
DK40182A (da) Dibenzofuranderivater og fremgangsmaade til fremstilling heraf
BG29646A2 (bg) 1,3-дизаместени карбамиди и 2- тиокарбамиди , метод за тяхното п получаване и приложението им
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
ATE13670T1 (de) 5,6-dihydro-11-alkylen-morphantridin-6-one, ihre herstellung und diese enthaltende arzneimittel.
AU9107682A (en) 3,7alpha-diazacyclohepta(j,k)fluoriene derivatives
JPS5217648A (en) Dc stabilizing power source system
NO922808D0 (no) Maksimalt miljoevennlige kjemiske reaksjoner som fremgangsmaate til fremstilling av nye miljoevernvennlige materialtyper og spesialprodukter
DK0457023T3 (da) Hydrochinondiether, fremgangsmåde til fremstilling heraf og anvendelse heraf
NO933465D0 (no) Legemidler inneholdende 1,5,6,7-tetrahydro -4- indazol -4- on-derivater, nye 1,5,6,7 - tetrahydro -4- indazol -4- on-derivater, og fremgangsmaate for deres fremstilling
DK341582A (da) Substituerede n-carbamoylmethylhalogenacetanilider og fremgangsmaade til fremstilling heraf
JPS5427559A (en) 1-(4-butyl) benzoylpyrrolidine and bactericides containing the same
ATE12393T1 (de) Synthese von 1rs,4sr,5rs-4-(4,8-dimethyl-5hydroxy-7-nonen-1-yl)-4-methyl-3,8dioxabicyclo(3.2.1)octan-1-essigs|ure und verwandte verbindungen.